TSE:BCT BriaCell Therapeutics (BCT) Stock Price, News & Analysis C$4.87 -0.08 (-1.62%) As of 03:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsNews and Trends About BriaCell Therapeutics Stock (TSE:BCT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BriaCell Therapeutics alerts:Sign Up Key Stats Today's RangeC$4.82▼C$4.8750-Day RangeC$4.35▼C$5.6252-Week RangeC$3.68▼C$20.40Volume203 shsAverage Volume17,027 shsMarket CapitalizationC$42.37 millionP/E RatioN/ADividend Yield13.70%Price TargetN/AConsensus RatingN/A Company Overview BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients' lives. Immunotherapies have become the forefront of the fight against cancer because they use the body's immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence. Read More Receive BCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCT Stock News HeadlinesBriaCell Therapeutics (TSE:BCT) Stock Price Down 2% - What's Next?September 3 at 2:00 AM | americanbankingnews.comBriaCell Therapeutics Corp.: BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMTJuly 15, 2026 | finanznachrichten.deTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.September 3 at 1:00 AM | Porter & Company (Ad)BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™July 15, 2026 | finance.yahoo.comBriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™July 7, 2026 | finance.yahoo.comBriaCell Therapeutics Corp.: BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast CancerMay 6, 2026 | finanznachrichten.deBriaCell: Advancing Toward Approval with Late-Stage Breast Cancer ImmunotherapyApril 17, 2026 | theglobeandmail.comBriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual MeetingMarch 20, 2026 | theglobeandmail.comSee More Headlines BCT Stock Analysis - Frequently Asked Questions How have BCT shares performed this year? BriaCell Therapeutics' stock was trading at C$9.80 on January 1st, 2026. Since then, BCT stock has decreased by 50.3% and is now trading at C$4.87. When did BriaCell Therapeutics' stock split? BriaCell Therapeutics shares reverse split on Sunday, August 24th 2025.The 1-10 reverse split was announced on Sunday, August 24th 2025. The number of shares owned by shareholders was adjusted after the market closes on Sunday, August 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of BriaCell Therapeutics? Shares of BCT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Industry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolTSE:BCT CIKN/A Webwww.briacell.com Phone604-921-1810FaxN/AEmployees16Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$2.37 million Net MarginsN/A Pretax MarginN/A Return on Equity-147.92% Return on Assets-122.71% Debt Debt-to-Equity RatioN/A Current Ratio7.07 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$3.23 per share Price / Book1.51Miscellaneous Outstanding Shares8,700,000Free FloatN/AMarket CapC$42.37 million OptionableNot Optionable Beta2.26 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (TSE:BCT) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
